Sun Pharma to acquire a minor stake in Surgimatix, Inc.
Mumbai, Feb. 20 -- Sun Pharmaceutical Industries has entered into an agreement with Surgimatix, Inc., pursuant to which Sun Pharma has agreed to acquire 16.33% shares of Surgimatix, Inc. for a cash consideration of USD 3.05 million.
Surgimatix, Inc., is a company incorporated in the State of Michigan, having its headquarters and registered office at Illinois, US. The Company
is engaged in the business of developing a proprietary soft tissue fixation device for laparoscopic hernia repair and other minimally invasive surgeries. Surgimatix, Inc., is yet to commence its
commercial operations.
Published by HT Digital Content Services with permission from Capital Market....
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.